Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Insight Molecular Diagnostics (IMDX) Equity Income (2020 - 2021)

Insight Molecular Diagnostics' Equity Income history spans 2 years, with the latest figure at -$270000.0 for Q1 2021.

  • For Q1 2021, Equity Income rose 17.93% year-over-year to -$270000.0; the TTM value through Dec 2021 reached -$270000.0, up 82.55%, while the annual FY2021 figure was -$270000.0, 82.55% up from the prior year.
  • Equity Income for Q1 2021 was -$270000.0 at Insight Molecular Diagnostics, up from -$435000.0 in the prior quarter.
  • Across five years, Equity Income topped out at -$270000.0 in Q1 2021 and bottomed at -$482000.0 in Q3 2020.